Acute Myelomonocytic Leukemia

Search Trials
A Study of H3B-8800 (RVT-2001) in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
Status:
Recruiting
Last Changed:
Apr 4, 2022
First Changed:
Jul 22, 2016
Disease(s):
Leukemia, Myeloid, Acute
Intervention(s):
H3B-8800 (RVT-2001)
Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
Status:
Not yet recruiting
Last Changed:
Mar 4, 2022
First Changed:
Feb 18, 2022
Disease(s):
Myelodysplastic Syndromes
Intervention(s):
RP7214
AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia
Status:
Not yet recruiting
Last Changed:
Jan 26, 2022
First Changed:
Jan 26, 2022
Disease(s):
Higher Risk Myelodysplastic Syndrome
Intervention(s):
AMG 176Azacitidine
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
Status:
Recruiting
Last Changed:
Jan 24, 2022
First Changed:
Aug 3, 2018
Disease(s):
Acute Myeloid Leukemia (AML)
Intervention(s):
VenetoclaxFludarabineBusulfanVenetoclaxAzacitidineDecitabine/cedazuridine
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MF and CMML (HSCT 002)
Status:
Not yet recruiting
Last Changed:
May 5, 2022
First Changed:
Feb 10, 2022
Disease(s):
Myelofibrosis
Intervention(s):
Tagraxofusp

Connect. Empower. Inspire.